Supriya Lifescience Limited (BOM:543434)

Supriya Lifescience Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	59,179	59,086	26,797	15,352	39,702	-
Market Cap Growth	120.50%	120.50%	74.55%	-61.33%	-	-
Enterprise Value	58,441	58,298	25,696	13,821	39,457	-
Last Close Price	735.60	733.55	331.31	190.06	490.41	-
PE Ratio	31.49	31.44	22.50	17.09	26.15	-
PS Ratio	8.50	8.48	4.70	3.33	7.49	-
PB Ratio	5.94	5.93	3.29	2.19	6.45	-
P/TBV Ratio	5.95	5.94	3.29	2.20	6.46	-
P/FCF Ratio	2574.12	2570.09	-	-	-	-
P/OCF Ratio	35.94	35.88	23.65	24.14	81.36	-
EV/Sales Ratio	8.39	8.37	4.51	3.00	7.44	-
EV/EBITDA Ratio	22.41	22.35	14.67	10.79	18.47	-
EV/EBIT Ratio	24.31	24.26	16.04	11.80	19.31	-
EV/FCF Ratio	2542.03	2535.82	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.01	0.03	0.05	0.27
Debt / EBITDA Ratio	0.02	0.02	0.03	0.17	0.13	0.42
Debt / FCF Ratio	2.34	2.34	-	-	-	2.61
Asset Turnover	0.69	0.69	0.66	0.59	0.90	1.00
Inventory Turnover	2.07	2.07	2.31	1.89	2.47	2.18
Quick Ratio	2.61	2.61	2.46	2.60	3.47	1.12
Current Ratio	5.32	5.32	5.17	4.85	4.99	1.82
Return on Equity (ROE)	20.74%	20.74%	15.73%	13.66%	34.34%	59.17%
Return on Assets (ROA)	14.77%	14.77%	11.50%	9.42%	21.64%	26.60%
Return on Capital (ROIC)	16.48%	16.48%	12.98%	10.73%	25.96%	36.20%
Return on Capital Employed (ROCE)	23.30%	23.30%	19.00%	16.20%	32.20%	55.60%
Earnings Yield	3.18%	3.18%	4.45%	5.85%	3.82%	-
FCF Yield	0.04%	0.04%	-1.21%	-2.89%	-0.28%	-
Dividend Yield	0.11%	0.14%	0.24%	0.32%	0.12%	-
Payout Ratio	3.43%	3.43%	4.05%	5.37%	2.89%	3.20%
Buyback Yield / Dilution	-0.02%	-0.02%	-	-	-9.97%	-
Total Shareholder Return	0.09%	0.12%	0.24%	0.32%	-9.85%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.